Morgan Stanley Reiterates Equal-Weight on CR Bard

by Emily Austin, Benzinga Staff Writer
July 18, 2011 7:52 AM | 14 seconds read |
Morgan Stanley reiterated its Equal-weight rating on CR Bard BCR. At the moment, the rating agency does not have a price target placed on the company's stock. On Friday, BCR lost 0.62% of its value to end the day at $111.80.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: ReiterationAnalyst RatingsHealth CareHealth Care EquipmentMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!